Bristol Myers Squibb aligns UK and US prices for new schizophrenia drug ○
found
a story from Financial Times ✅ › Financial Times
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Pharmaceutical companies are under pressure to lower prices on both sides of the Atlantic